Halozyme Therapeutics, Inc. Forecast and Target Price
$73.11
Halozyme Therapeutics, Inc. (HALO) Share Price Forecast
Currently 17 wall-street analysts regularly analyze the financials of Halozyme Therapeutics, Inc. on a frequent basis to provide recommendations along with target share price. 17 analysts offering 12-month price forecasts for Halozyme Therapeutics, Inc. (HALO) have a share price target of $76. This median of share price forecast represents a 3.95% upside from the latest price of $73.11 as on 07.01.26.
Halozyme Therapeutics, Inc. (HALO) Price vs Consensus Price Target
As per the chart shown above, analysts believe that the Halozyme Therapeutics, Inc. (HALO) share price will touch around $76 in next 12-months.
Halozyme Therapeutics, Inc. (HALO) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Halozyme Therapeutics, Inc.'s share price and its median forecast price. As on 07.01.26, the difference is -10.39%
Halozyme Therapeutics, Inc. (HALO): Difference between Current Price & Median Forecasted Price
Halozyme Therapeutics, Inc. (HALO) Share Price : Analyst Recommendation
Based on 17 analysts tracking and researching Halozyme Therapeutics, Inc. (HALO) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 11 | 12 | 12 |
| Outperform | 2 | 2 | 2 |
| Hold | 3 | 3 | 3 |
| Underperform | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 |